Prestige Biopharma Limited sell "Tuznue™ (Trastuzumab biosimilar)"
Basic Information
1.1K
31
9
4.4(48)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Tuznue™ (Trastuzumab biosimilar)
Manufacturer(s)
Specifications
- Expression System: Produced in Chinese Hamster Ovary (CHO) cell culture, consistent with the reference biologic trastuzumab
- Formulation Type: Lyophilized powder or concentrate reconstituted/diluted for intravenous infusion
- Regulatory Status: Approved biosimilar to Herceptin (trastuzumab) holding Marketing Authorisation from the European Commission
- Storage Condition: Store at 2-8°C, protected from light; do not freeze
Other Information
Additional Description:
Tuznue is a biosimilar to Herceptin (trastuzumab), created to give patients a more affordable treatment option while matching the original branded drug's efficacy and safety profile. It is indicated for HER2-positive metastatic breast cancer, HER2-positive early breast cancer, and HER2-positive metastatic gastric cancer, and holds Marketing Authorisation from the European Commission.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment